Bioxodes is a clinical stage biotech company specialized in the development of novel therapeutics using molecules derived from nature to prevent thrombosis and inflammatory processes.

 

NEWS

Bioxodes obtained authorization to launch phase I trial of its antithrombotic drug, Ir-CPI, in healthy male volunteers.